Alnylam Pharmaceuticals (ALNY) Stock Chart & Stock Price History → Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad) Free ALNY Stock Alerts $150.03 +3.10 (+2.11%) (As of 05/30/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Alnylam Pharmaceuticals Stock Price Performance5 Day Performance+1.54%1 Month Performance+4.22%3 Month Performance-0.70%6 Month Performance-10.83%Year-To-Date Performance-21.62%1 Year Performance-19.54% Receive ALNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. ALNY Stock Chart for Thursday, May, 30, 2024 ALNY Chart by TradingView Alnylam Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/29/2024$150.06$146.93-2.09%$149.76$146.87875,955 shs$18.59 billion05/28/2024$147.76$150.06+1.56%$152.98$148.40510,344 shs$18.98 billion05/27/2024$147.76$147.76$149.83$147.15506,800 shs$18.69 billion05/24/2024$149.38$147.76-1.08%$149.83$147.18506,806 shs$18.69 billion05/23/2024$150.90$149.38-1.01%$151.00$148.26500,522 shs$18.90 billion05/22/2024$149.62$150.90+0.86%$152.05$149.59350,720 shs$19.09 billion Get the Latest News and Ratings for ALNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/21/2024$150.24$149.62-0.41%$151.45$147.89448,133 shs$18.93 billion05/20/2024$149.40$150.24+0.56%$150.78$147.80368,454 shs$19.00 billion05/17/2024$151.22$149.40-1.20%$151.84$148.32407,572 shs$18.90 billion05/16/2024$147.40$151.22+2.59%$151.44$144.80934,860 shs$19.13 billion05/15/2024$147.89$147.40-0.33%$151.15$147.00536,142 shs$18.64 billion05/14/2024$149.89$147.89-1.33%$151.63$147.02604,169 shs$18.71 billion05/13/2024$150.47$149.89-0.39%$152.67$149.00512,792 shs$18.96 billion05/10/2024$151.37$150.47-0.59%$151.81$148.76322,785 shs$19.03 billion05/09/2024$152.29$151.37-0.60%$153.00$150.37329,246 shs$19.15 billion05/08/2024$154.33$152.29-1.32%$155.49$152.19451,069 shs$19.26 billion05/07/2024$151.22$154.33+2.06%$155.04$150.83353,436 shs$19.52 billion05/06/2024$152.33$151.22-0.73%$152.82$149.52289,742 shs$19.13 billion05/03/2024$150.31$152.33+1.34%$155.41$151.84452,157 shs$19.19 billion05/02/2024$149.96$150.31+0.23%$153.85$147.29660,073 shs$18.93 billion05/01/2024$143.95$149.96+4.18%$151.95$143.96735,763 shs$18.89 billion04/30/2024$147.36$143.95-2.31%$148.05$143.81477,037 shs$18.13 billion04/29/2024$143.31$147.36+2.83%$148.49$143.50439,847 shs$18.56 billion04/26/2024$143.71$143.31-0.28%$146.07$143.00479,138 shs$18.05 billion04/25/2024$143.80$143.71-0.06%$145.79$141.98489,263 shs$18.10 billion04/24/2024$146.07$143.80-1.55%$147.49$143.52395,369 shs$18.11 billion04/23/2024$145.79$146.07+0.19%$150.27$145.04543,726 shs$18.40 billion04/22/2024$144.41$145.79+0.96%$147.86$143.69399,984 shs$18.36 billion04/19/2024$145.16$144.41-0.52%$146.92$143.51703,168 shs$18.19 billion04/18/2024$145.32$145.16-0.11%$146.45$144.50398,901 shs$18.28 billion04/17/2024$146.72$145.32-0.95%$147.49$145.19601,282 shs$18.30 billion04/16/2024$147.70$146.72-0.66%$148.44$146.01352,424 shs$18.48 billion04/15/2024$148.50$147.70-0.54%$150.37$146.73498,935 shs$18.60 billion04/12/2024$152.09$148.50-2.36%$151.80$148.28427,819 shs$18.70 billion04/11/2024$152.41$152.09-0.21%$154.02$149.93473,409 shs$19.16 billion04/10/2024$155.90$152.41-2.24%$154.96$151.91571,298 shs$19.20 billion04/09/2024$156.04$155.90-0.09%$159.34$154.89595,956 shs$19.64 billion04/08/2024$153.56$156.04+1.62%$157.96$153.25738,213 shs$19.65 billion04/05/2024$151.48$153.56+1.37%$154.00$149.41351,489 shs$19.34 billion04/04/2024$150.83$151.48+0.43%$154.34$150.81531,882 shs$19.08 billionNvidia’s Quiet $1 Trillion Pivot (Ad)Nvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately.04/03/2024$151.04$150.83-0.14%$151.27$149.25315,048 shs$19.00 billion04/02/2024$153.33$151.04-1.49%$152.27$150.67445,640 shs$19.02 billion04/01/2024$149.45$153.33+2.60%$154.20$147.58523,250 shs$19.31 billion03/29/2024$149.45$149.45$154.50$149.32666,592 shs$18.82 billion03/28/2024$154.39$149.45-3.20%$154.50$149.32666,576 shs$18.82 billion03/27/2024$151.97$154.39+1.59%$155.28$150.40463,043 shs$19.45 billion03/26/2024$152.07$151.97-0.07%$153.43$150.81532,230 shs$19.14 billion03/25/2024$146.51$152.07+3.79%$152.63$147.13799,298 shs$19.15 billion03/22/2024$146.62$146.51-0.08%$147.10$143.66834,175 shs$18.45 billion03/21/2024$147.99$146.62-0.93%$150.68$145.41611,511 shs$18.47 billion03/20/2024$148.17$147.99-0.12%$148.64$145.22439,772 shs$18.64 billion03/19/2024$147.41$148.17+0.52%$149.69$146.00517,163 shs$18.66 billion03/18/2024$149.27$147.41-1.25%$151.00$147.22460,718 shs$18.57 billion03/15/2024$148.53$149.27+0.50%$150.09$145.54905,205 shs$18.80 billion03/14/2024$148.42$148.53+0.07%$149.59$145.77505,840 shs$18.71 billion03/13/2024$146.65$148.42+1.21%$151.46$146.82858,993 shs$18.69 billion03/12/2024$149.10$146.65-1.64%$150.02$146.61683,429 shs$18.47 billion03/11/2024$149.82$149.10-0.48%$152.50$148.88661,992 shs$18.78 billion03/08/2024$149.86$149.82-0.03%$152.88$149.14637,629 shs$18.87 billion03/07/2024$149.66$149.86+0.13%$150.56$149.24563,928 shs$18.87 billion03/06/2024$149.68$149.66-0.01%$150.24$147.63521,529 shs$18.85 billion03/05/2024$150.04$149.68-0.24%$151.21$147.52620,483 shs$18.85 billion03/04/2024$152.61$150.04-1.68%$154.85$149.89950,685 shs$18.90 billion03/01/2024$151.09$152.61+1.01%$155.91$150.00523,455 shs$19.22 billion02/29/2024$155.23$151.09-2.67%$157.52$149.001.81 million shs$19.03 billion Related Companies: Royalty Pharma Stock Price Chart BeiGene Stock Price Chart Sarepta Therapeutics Stock Price Chart Catalent Stock Price Chart Elanco Animal Health Stock Price Chart Biogen Stock Price Chart Neurocrine Biosciences Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Incyte Stock Price Chart United Therapeutics Stock Price Chart Receive ALNY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALNY) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaThe only financial event in 2024 that matters Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.